Contact
Please use this form to send email to PR contact of this press release:
Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate
TO:
Please use this form to send email to PR contact of this press release:
Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate
TO: